Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Shirley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Genomics|June 4, 2013
Sensitive and specific detection of mosaic chromosomal abnormalities using the Parent-of-Origin-based Detection (POD) methodJoseph D Baugher, Benjamin D Baugher, Matthew D Shirley, et al.
Plos One|November 28, 2012
Unexpected relationships and inbreeding in HapMap phase III populationsEric L Stevens, Joseph D Baugher, Matthew D Shirley, et al.
Human Mutation|March 1, 2012
Chromosomal variation in lymphoblastoid cell linesMatthew D Shirley, Joseph D Baugher, Eric L Stevens, et al.
Plos One|March 3, 2016
Copy Number Variants Associated with 14 Cases of Self-Injurious BehaviorMatthew D Shirley, Laurence Frelin, José Soria López, et al.
The New England Journal of Medicine|May 10, 2013
Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQMatthew D Shirley, Hao Tang, Carol J Gallione, et al.
Molecular Cancer Research : MCR|March 12, 2021
RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell ProliferationMatthew S Crowe, Tatiana Zavorotinskaya, Charles F Voliva, et al.
Molecular Cancer Research : MCR|September 12, 2018
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant MelanomaGrace P Leung, Tianshu Feng, Frederic D Sigoillot, et al.
Cancer Research|January 28, 2021
Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal MicroenvironmentHui Qin Wang, Iain J Mulford, Fiona Sharp, et al.
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Genomics|June 4, 2013
Sensitive and specific detection of mosaic chromosomal abnormalities using the Parent-of-Origin-based Detection (POD) methodJoseph D Baugher, Benjamin D Baugher, Matthew D Shirley, et al.
Plos One|November 28, 2012
Unexpected relationships and inbreeding in HapMap phase III populationsEric L Stevens, Joseph D Baugher, Matthew D Shirley, et al.
Human Mutation|March 1, 2012
Chromosomal variation in lymphoblastoid cell linesMatthew D Shirley, Joseph D Baugher, Eric L Stevens, et al.
Plos One|March 3, 2016
Copy Number Variants Associated with 14 Cases of Self-Injurious BehaviorMatthew D Shirley, Laurence Frelin, José Soria López, et al.
The New England Journal of Medicine|May 10, 2013
Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQMatthew D Shirley, Hao Tang, Carol J Gallione, et al.
Molecular Cancer Research : MCR|March 12, 2021
RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell ProliferationMatthew S Crowe, Tatiana Zavorotinskaya, Charles F Voliva, et al.
Molecular Cancer Research : MCR|September 12, 2018
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant MelanomaGrace P Leung, Tianshu Feng, Frederic D Sigoillot, et al.
Cancer Research|January 28, 2021
Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal MicroenvironmentHui Qin Wang, Iain J Mulford, Fiona Sharp, et al.
Nature Cancer|January 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomasAhmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn, et al.
Molecular Cancer Therapeutics|August 5, 2020
The Discovery of SWI/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal MelanomaFlorencia Rago, GiNell Elliott, Ailing Li, et al.
Pageof 2